Showing results (131-140 of 168) with videos related to

Sort By:
Pageof 17
Journal of Virology|September 1, 1997
Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1b12. offH Mo, L Stamatatos, J E Ip, et al.
Clinical and Experimental Immunology|November 28, 2002
Characteristics of immunity induced by viral antigen or conferred by antibody via different administration routesT Matsuoka, Y Okamoto, Z Matsuzaki, et al.
Journal of Virology|March 12, 1999
Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccinesH Sakurai, R A Williamson, J E Crowe, et al.
Biophysical Chemistry|January 24, 2002
Crystallohydrodynamics for solving the hydration problem for multi-domain proteins: open physiological conformations for human IgGB Carrasco, J Garcia de la Torre, K G Davis, et al.
Biochemical and Biophysical Research Communications|October 12, 2000
Copper refolding of prion proteinB S Wong, C Vénien-Bryan, R A Williamson, et al.
Journal of Virology|December 1, 1996
In vitro antigen challenge of human antibody libraries for vaccine evaluation: the human immunodeficiency virus type 1 envelopeP W Parren, P Fisicaro, A F Labrijn, et al.
Science (New York, N.Y.)|December 8, 1989
Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambdaW D Huse, L Sastry, S A Iverson, et al.
The Journal of General Virology|May 6, 1998
Human recombinant Puumala virus antibodies: cross-reaction with other hantaviruses and use in diagnosticsE M Salonen, P W Parren, Y F Graus, et al.
Immunity|May 6, 1999
Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivoP Poignard, R Sabbe, G R Picchio, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1997
Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodiesY F Graus, M H de Baets, P W Parren, et al.
Pageof 17